You are here

April 14, 2016 - The manuscript „Clustering of comorbidities is related to age and sex and impacts clinical outcome in Myelodysplastic Syndromes“ received the prestigious "Dr.-Johannes-Tuba-Award" 2015

"Dr.-Johannes-Tuba-Award" 2015 for Geriatrics and Gerontology   

The manuscript „Clustering of comorbidities is related to age and sex and impacts clinical outcome in Myelodysplastic Syndromes“ by Christoph Bammer, MD from the group of Reinhard Stauder MD, MSc, associate professor, published in JGO in 2014 has received the prestigious "Dr.-Johannes-Tuba-Award" 2015 for Geriatrics and Gerontology of the Tyrolean Medical Society

Myelodysplastic syndromes (MDS) represent typical diseases of the elderly, displaying a median age of about 74 yrs at initial diagnosis. The clinical outcome of a well-characterized cohort of patients with MDS from the Austrian MDS task force was analyzed for prevalence and impact of comorbidities to establish the basis for tailored treatment algorithms. Focus was on age- and sex-related differences. In 616 patients a relevant proportion displayed one (24.5%) or more (23.7%) comorbidities as assessed by the hematopoietic cell transplantation-comorbidity index (HCT-CI). Distinct comorbidities clustered in an age- and sex-related manner, which may have clinical implications when designing individualized therapies. Moreover, HCT-CI risk grouping remained an independent prognostic parameter for survival in multivariate analysis. Thus, comorbidities should be evaluated with established scores and integrated in decision making in MDS-patients.

The "Dr.-Johannes-Tuba-Award" was provided by the late Hertha Tuba to the Tyrolean Medical Society in memory of her deceased (late) husband Dr.-Johannes-Tuba-Award, who was one of the pioneers in geriatrics and gerontology in the county of Tyrol, Austria. 

Reinhard Stauder is the National Representative for Austria in SIOG. His main clinical and scientific focus lies in Myelodysplastic Syndromes (MDS), in the implementation of geriatric assessment in hematologic malignancies and in anemia in the elderly.

Links: